SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001683168-23-008109
Filing Date
2023-11-14
Accepted
2023-11-14 15:13:25
Documents
1
Group Members
PETER E. DEUTSCH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G aeglea_sch13g.htm SC 13G 44929
  Complete submission text file 0001683168-23-008109.txt   46235
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89456 | Film No.: 231404973
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25 EAST POINT LANE OLD GREENWICH CT 06870
Business Address
Deutsch Peter E. (Filed by) CIK: 0001998610 (see all company filings)

Type: SC 13G